Glanum Innovation IVS: Financial statements 2019
CVR: 37682837
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
Glanum Innovation IVS (CVR 37682837) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 7,583 and a net result of DKK 7,583 compared with DKK 4,877 the year before. That is an increase of 21.3% compared with the year before. Equity in the 2019 report amounted to DKK 7,162. The solvency ratio was 100%.
- Revenue
- DKK 0
- Gross Profit
- DKK 7,583
- Profit/Loss
- DKK 7,583
- Equity
- DKK 7,162
- Total Assets
- DKK 7,162
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | 0 | 8K | 8K | 7K | - |
| 2018 | 34K | 6K | 5K | 15K | - |
| 2017 | 55K | 4K | 3K | 38K | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
Glanum Innovation IVS has published its annual report for 2018. Revenue came to DKK 33,570, and the net result was DKK 4,877.
About Glanum Innovation IVS
Glanum Innovation IVS was a Danish company of the type Iværksætterselskab based in Værløse, founded in 2016. The company has been dissolved on 4 February 2020. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. In 2019, the company reported a gross profit of DKK 7,583 and a net result of DKK 7,583 compared with DKK 4,877 the year before. Equity in the 2019 report amounted to DKK 7,162.